1:27 PM - 1:39 PM
[30-413-pm02S] Development of bivalent fusion inhibitors targeting HIV-1 gp41 protein
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
Oral Presentation
(A) Pharmaceutical Chemistry
Sat. Mar 30, 2024 1:15 PM - 2:15 PM [Room 413] Conference Center 413 (4F)
Chair: Atsuhiko Taniguchi, Noriko Saito-Tarashima
1:27 PM - 1:39 PM
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.